6 results Financial Regulatory – Update Q1 2021 Traditionally, 1 January (and 1 July) each year is a date on which new Dutch financial regulations enter into force. This year, the amendments to the Dutch Financial Supervision Act are relatively few, but other developments are worthy of attention. Stibbe advises Advantest Corporation on the acquisition of Salland Engineering Stibbe has successfully assisted Advantest Corporation in their acquisition of Salland Engineering. Under this acquisition, Salland Engineering will be an independent, wholly-owned (indirect) subsidiary of Advantest Europe GmbH. Nicolas Pradel Senior Associate Luxembourg Stibbe advises Odyssey Acquisition Stibbe advises Odyssey Acquisition on its EUR 1.5 billion business combination With BenevolentAI. Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.
Financial Regulatory – Update Q1 2021 Traditionally, 1 January (and 1 July) each year is a date on which new Dutch financial regulations enter into force. This year, the amendments to the Dutch Financial Supervision Act are relatively few, but other developments are worthy of attention.
Stibbe advises Advantest Corporation on the acquisition of Salland Engineering Stibbe has successfully assisted Advantest Corporation in their acquisition of Salland Engineering. Under this acquisition, Salland Engineering will be an independent, wholly-owned (indirect) subsidiary of Advantest Europe GmbH.
Stibbe advises Odyssey Acquisition Stibbe advises Odyssey Acquisition on its EUR 1.5 billion business combination With BenevolentAI.
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.